Bayview Pharmacy's Lidocaine 10%/Tetracaine 4%/Prilocaine HCl 10%/Phenylephrine HCl 1% Topical Gel is a compounded formulation that combines the anesthetic properties of lidocaine, tetracaine, and prilocaine HCl with the vasoconstrictor and anti-inflammatory effects of phenylephrine HCl. This powerful blend is designed to provide targeted relief from pain, itching, and inflammation associated with minor skin irritations, sunburns, insect bites, minor cuts and scrapes, minor burns, hemorrhoids, and anal fissures.

The semisolid formulation is dispensed through a pump mechanism, facilitating easy and precise application on the skin. The gel-like consistency allows for optimal absorption of the active ingredients, ensuring effective treatment of the affected area. Lidocaine provides a numbing effect, while tetracaine and prilocaine HCl enhance the anesthetic effects. Phenylephrine HCl reduces inflammation and swelling, and its vasoconstrictor properties help to minimize the risk of bleeding.

This topical gel is safe and effective for use in adults and children over the age of two. It should be applied as directed by a healthcare professional. To ensure safety, avoid contact with the eyes and mucous membranes, and do not use this product for more than seven days without consulting a healthcare professional.

If you have any questions about the Lidocaine 10%/Tetracaine 4%/Prilocaine HCl 10%/Phenylephrine HCl 1% Topical Gel, please do not hesitate to contact us. Our team of compounding pharmacists is here to provide the information and support you need.

This compounded formulation of Lidocaine 10%/Tetracaine 4%/Prilocaine HCl 10%/Phenylephrine HCl 1% Topical Gel is a semisolid preparation designed for easy and precise application on the skin. It is primarily used for the treatment of pain associated with minor cuts, scrapes, and burns, and to provide local anesthesia for minor surgical procedures. It is not recommended for deep or puncture wounds, animal bites, or serious burns.

Patients should avoid contact with the eyes and mucous membranes. If contact occurs, the area should be flushed with water immediately. It is also advised to avoid application on open wounds or broken skin. The use of this product should not exceed 7 days unless directed by a healthcare provider. If symptoms persist or worsen, patients should seek medical advice.

Patients with allergies to any of the ingredients, those who are pregnant or breastfeeding, and those taking other medications, including over-the-counter drugs, vitamins, and herbal supplements, should avoid using this product. It is also not recommended for patients with medical conditions such as heart disease, high blood pressure, diabetes, or kidney disease.

Patients with a history of sensitivity to local anesthetics, seizures, liver or kidney disease, glaucoma, asthma, allergies to any of the ingredients, bleeding disorders, alcohol or drug abuse, or mental illness should also avoid using this product. If you have any questions about this formulation or its interaction with other medications, please consult with a healthcare provider.

Lidocaine 10%/Tetracaine 4%/Prilocaine HCl 10%/Phenylephrine HCl 1% Topical Gel is a compounded formulation that combines four active ingredients to provide targeted relief from pain and inflammation. This semisolid formulation is dispensed through a pump mechanism, ensuring easy and precise application on the skin.

Lidocaine, Tetracaine, and Prilocaine HCl are local anesthetics that work synergistically to block nerve signals from reaching the brain, thereby providing temporary relief from pain. Phenylephrine HCl, on the other hand, is a vasoconstrictor that narrows the blood vessels, reducing inflammation and further alleviating pain.

This topical gel can be used to manage pain and inflammation associated with various conditions such as muscle and joint pain, arthritis, and nerve pain. It is also effective in treating skin conditions like eczema, psoriasis, and dermatitis. The gel-like consistency allows for the active ingredients to be absorbed directly into the affected area, providing targeted treatment.

To use this formulation, apply a thin layer of the gel to the affected area and gently massage it in until it is completely absorbed. It is recommended not to apply more than four times daily. If any irritation or discomfort is experienced, discontinue use and consult with your healthcare provider immediately.

It is important to remember that while this formulation can provide significant relief, it is not a cure for the underlying condition. Always consult with your healthcare provider for a comprehensive treatment plan. If you have any questions about this formulation or its use, do not hesitate to reach out to your healthcare provider or pharmacist.

This compounded formulation of Lidocaine 10%/Tetracaine 4%/Prilocaine HCl 10%/Phenylephrine HCl 1% Topical Gel is a semisolid preparation that is dispensed through a pump mechanism. This design allows for easy and precise application on the skin, targeting the specific area for treatment or absorption of the active ingredients. The gel-like consistency of the formulation ensures a smooth application process.

The formulation is versatile and can be used to treat a variety of minor skin conditions. It is effective in treating minor cuts, scrapes, and abrasions, providing relief from pain and itching. It can also be used to alleviate discomfort associated with minor skin irritations such as poison ivy, poison oak, and poison sumac.

Furthermore, this formulation can be used to reduce the pain and discomfort associated with minor burns, sunburns, insect bites, dermatitis, and eczema. It is also effective in reducing the swelling and redness associated with these conditions. However, it is important to note that this formulation should not be used on open wounds or on areas of the skin that are infected or inflamed.

If you have any questions about the use of this formulation, please do not hesitate to reach out for further information. It is always recommended to consult with a healthcare professional before starting any new treatment regimen.